CM
DERM

Castleark Management’s Dermira, Inc. DERM Stock Holding History

Castleark Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-177,444
Closed -$5.17M – 435
2017
Q2 		$5.17M Sell
177,444
-2,172
-1% -$66K 0.17% 177
2017
Q1 		$6.13M Buy
+179,616
New +$5.79M 0.19% 166

Other funds holding DERM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Castleark Management's DERM Position: Q3 2017 in Review

Castleark Management sold out of Dermira, Inc. (DERM) in Q3 2017, closing a stake of 177,444 shares — an estimated $5.17M sold.

Castleark Management first reported a position in DERM in Q1 2017 and held it in 2 quarters. The position peaked at $6.13M in Q1 2017. 123 funds tracked by Wall St. Rank hold DERM as of Q3 2017.

  • Castleark Management reported no remaining Dermira, Inc. position as of Q3 2017 after selling out during the quarter.
  • Castleark Management sold 177,444 Dermira, Inc. shares in Q3 2017, an estimated $5.17M.
  • Castleark Management first reported a position in Dermira, Inc. in Q1 2017 and held it in 2 quarters.
  • Castleark Management's Dermira, Inc. position peaked at $6.13M in Q1 2017.
  • 123 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2017.

Based on Castleark Management's 13F filing for Q3 2017, filed 15 Nov 2017.